Members of Kyowa Kirin’s leadership team in front of the building at 130 N. Steele St. that the company will occupy for two years beginning in February. Photo courtesy of Kyowa Kirin. Kyowa ...
Cimeio Therapeutics announced today that it has entered a research collaboration with Kyowa Kirin Co., Ltd. (Kyowa Kirin) to ...
German pharma Grünenthal has started the process of taking ownership of 13 ageing medicines developed by Japan's Kyowa Kirin, which are currently sold by affiliate companies across Europe. The ...
Kura Oncology, Inc.'s partnership and promising AML treatment make it a top stock pick with significant upside potential for ...
Credit: Rachaphak/Shutterstock. Kura Oncology has partnered Kyowa Kirin in a strategic global collaboration to develop and commercialise oral ziftomenib, an investigational menin inhibitor ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Kura Oncology, Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor ziftomenib showed encouraging data across ...
Interim analysis from Phase 1a portion of KOMET-007 shows 100% CR rate in NPM1-m and 83% CR rate in KMT2A-r 1L adverse risk AML with 7+3 –– ...
Nov 20 (Reuters) - Kura Oncology (KURA.O), opens new tab said on Wednesday it will collaborate with Japan's Kyowa Kirin (4151.T), opens new tab to develop and commercialize the blood cancer ...
Kura Oncology (KURA) and Kyowa Kirin provided encouraging clinical data from KOMET-007, a Phase 1 dose-escalation trial of ziftomenib, a highly ...
Kura Oncology, Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor ziftomenib showed encouraging data across multiple studies, the most encouraging of which were in combination with other ...
Cimeio Therapeutics announced today that it has entered a research collaboration with Kyowa Kirin Co., Ltd. (Kyowa Kirin) to develop a novel therapy for diseases with high unmet need. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback